Global Non-Alcoholic Steatohepatitis Biomarkers Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Non-Alcoholic Steatohepatitis Biomarkers market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Non-Alcoholic Steatohepatitis Biomarkers market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Non-Alcoholic Steatohepatitis Biomarkers market size and forecasts, in consumption value ($ Million), 2018-2029
Global Non-Alcoholic Steatohepatitis Biomarkers market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Non-Alcoholic Steatohepatitis Biomarkers market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Non-Alcoholic Steatohepatitis Biomarkers market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Alcoholic Steatohepatitis Biomarkers
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Alcoholic Steatohepatitis Biomarkers market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Genfit, Prometheus Laboratories, Siemens Medical Solutions USA, BioPredictive and Quest Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Non-Alcoholic Steatohepatitis Biomarkers market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Non-Alcoholic Steatohepatitis Biomarkers product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-Alcoholic Steatohepatitis Biomarkers, with revenue, gross margin and global market share of Non-Alcoholic Steatohepatitis Biomarkers from 2018 to 2023.
Chapter 3, the Non-Alcoholic Steatohepatitis Biomarkers competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Non-Alcoholic Steatohepatitis Biomarkers market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Alcoholic Steatohepatitis Biomarkers.
Chapter 13, to describe Non-Alcoholic Steatohepatitis Biomarkers research findings and conclusion.
This report is a detailed and comprehensive analysis for global Non-Alcoholic Steatohepatitis Biomarkers market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Non-Alcoholic Steatohepatitis Biomarkers market size and forecasts, in consumption value ($ Million), 2018-2029
Global Non-Alcoholic Steatohepatitis Biomarkers market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Non-Alcoholic Steatohepatitis Biomarkers market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Non-Alcoholic Steatohepatitis Biomarkers market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Alcoholic Steatohepatitis Biomarkers
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Alcoholic Steatohepatitis Biomarkers market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Genfit, Prometheus Laboratories, Siemens Medical Solutions USA, BioPredictive and Quest Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Non-Alcoholic Steatohepatitis Biomarkers market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Hepatic Fibrosis Biomarkers
- Serum Biomarkers
- Oxidative Stress Biomarkers
- Apoptosis Biomarkers
- Others
- Hospital
- Pharmaceutical Company
- Others
- Genfit
- Prometheus Laboratories
- Siemens Medical Solutions USA
- BioPredictive
- Quest Diagnostics
- AstraZeneca Plc.
- Laboratory Corporation of America Holdings
- Pfizer
- Bristol-Myers Squibb Company
- NGM Biopharmaceuticals
- Gilead Sciences
- Perspectum Diagnostics
- One Way Liver SL
- Enterome SA
- Echosens SA
- Cisbio Bioassays SAS
- Celerion Inc.
- Xeptagen SpA
- Boehringer Ingelheim
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Non-Alcoholic Steatohepatitis Biomarkers product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-Alcoholic Steatohepatitis Biomarkers, with revenue, gross margin and global market share of Non-Alcoholic Steatohepatitis Biomarkers from 2018 to 2023.
Chapter 3, the Non-Alcoholic Steatohepatitis Biomarkers competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Non-Alcoholic Steatohepatitis Biomarkers market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Alcoholic Steatohepatitis Biomarkers.
Chapter 13, to describe Non-Alcoholic Steatohepatitis Biomarkers research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Non-Alcoholic Steatohepatitis Biomarkers
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-Alcoholic Steatohepatitis Biomarkers by Type
1.3.1 Overview: Global Non-Alcoholic Steatohepatitis Biomarkers Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Type in 2022
1.3.3 Hepatic Fibrosis Biomarkers
1.3.4 Serum Biomarkers
1.3.5 Oxidative Stress Biomarkers
1.3.6 Apoptosis Biomarkers
1.3.7 Others
1.4 Global Non-Alcoholic Steatohepatitis Biomarkers Market by Application
1.4.1 Overview: Global Non-Alcoholic Steatohepatitis Biomarkers Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Pharmaceutical Company
1.4.4 Others
1.5 Global Non-Alcoholic Steatohepatitis Biomarkers Market Size & Forecast
1.6 Global Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast by Region
1.6.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Non-Alcoholic Steatohepatitis Biomarkers Market Size by Region, (2018-2029)
1.6.3 North America Non-Alcoholic Steatohepatitis Biomarkers Market Size and Prospect (2018-2029)
1.6.4 Europe Non-Alcoholic Steatohepatitis Biomarkers Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Market Size and Prospect (2018-2029)
1.6.6 South America Non-Alcoholic Steatohepatitis Biomarkers Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Genfit
2.1.1 Genfit Details
2.1.2 Genfit Major Business
2.1.3 Genfit Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.1.4 Genfit Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Genfit Recent Developments and Future Plans
2.2 Prometheus Laboratories
2.2.1 Prometheus Laboratories Details
2.2.2 Prometheus Laboratories Major Business
2.2.3 Prometheus Laboratories Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.2.4 Prometheus Laboratories Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Prometheus Laboratories Recent Developments and Future Plans
2.3 Siemens Medical Solutions USA
2.3.1 Siemens Medical Solutions USA Details
2.3.2 Siemens Medical Solutions USA Major Business
2.3.3 Siemens Medical Solutions USA Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.3.4 Siemens Medical Solutions USA Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Siemens Medical Solutions USA Recent Developments and Future Plans
2.4 BioPredictive
2.4.1 BioPredictive Details
2.4.2 BioPredictive Major Business
2.4.3 BioPredictive Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.4.4 BioPredictive Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BioPredictive Recent Developments and Future Plans
2.5 Quest Diagnostics
2.5.1 Quest Diagnostics Details
2.5.2 Quest Diagnostics Major Business
2.5.3 Quest Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.5.4 Quest Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Quest Diagnostics Recent Developments and Future Plans
2.6 AstraZeneca Plc.
2.6.1 AstraZeneca Plc. Details
2.6.2 AstraZeneca Plc. Major Business
2.6.3 AstraZeneca Plc. Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.6.4 AstraZeneca Plc. Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 AstraZeneca Plc. Recent Developments and Future Plans
2.7 Laboratory Corporation of America Holdings
2.7.1 Laboratory Corporation of America Holdings Details
2.7.2 Laboratory Corporation of America Holdings Major Business
2.7.3 Laboratory Corporation of America Holdings Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.7.4 Laboratory Corporation of America Holdings Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.8.4 Pfizer Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 Bristol-Myers Squibb Company
2.9.1 Bristol-Myers Squibb Company Details
2.9.2 Bristol-Myers Squibb Company Major Business
2.9.3 Bristol-Myers Squibb Company Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.9.4 Bristol-Myers Squibb Company Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
2.10 NGM Biopharmaceuticals
2.10.1 NGM Biopharmaceuticals Details
2.10.2 NGM Biopharmaceuticals Major Business
2.10.3 NGM Biopharmaceuticals Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.10.4 NGM Biopharmaceuticals Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 NGM Biopharmaceuticals Recent Developments and Future Plans
2.11 Gilead Sciences
2.11.1 Gilead Sciences Details
2.11.2 Gilead Sciences Major Business
2.11.3 Gilead Sciences Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.11.4 Gilead Sciences Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Gilead Sciences Recent Developments and Future Plans
2.12 Perspectum Diagnostics
2.12.1 Perspectum Diagnostics Details
2.12.2 Perspectum Diagnostics Major Business
2.12.3 Perspectum Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.12.4 Perspectum Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Perspectum Diagnostics Recent Developments and Future Plans
2.13 One Way Liver SL
2.13.1 One Way Liver SL Details
2.13.2 One Way Liver SL Major Business
2.13.3 One Way Liver SL Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.13.4 One Way Liver SL Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 One Way Liver SL Recent Developments and Future Plans
2.14 Enterome SA
2.14.1 Enterome SA Details
2.14.2 Enterome SA Major Business
2.14.3 Enterome SA Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.14.4 Enterome SA Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Enterome SA Recent Developments and Future Plans
2.15 Echosens SA
2.15.1 Echosens SA Details
2.15.2 Echosens SA Major Business
2.15.3 Echosens SA Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.15.4 Echosens SA Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Echosens SA Recent Developments and Future Plans
2.16 Cisbio Bioassays SAS
2.16.1 Cisbio Bioassays SAS Details
2.16.2 Cisbio Bioassays SAS Major Business
2.16.3 Cisbio Bioassays SAS Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.16.4 Cisbio Bioassays SAS Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Cisbio Bioassays SAS Recent Developments and Future Plans
2.17 Celerion Inc.
2.17.1 Celerion Inc. Details
2.17.2 Celerion Inc. Major Business
2.17.3 Celerion Inc. Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.17.4 Celerion Inc. Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Celerion Inc. Recent Developments and Future Plans
2.18 Xeptagen SpA
2.18.1 Xeptagen SpA Details
2.18.2 Xeptagen SpA Major Business
2.18.3 Xeptagen SpA Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.18.4 Xeptagen SpA Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Xeptagen SpA Recent Developments and Future Plans
2.19 Boehringer Ingelheim
2.19.1 Boehringer Ingelheim Details
2.19.2 Boehringer Ingelheim Major Business
2.19.3 Boehringer Ingelheim Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.19.4 Boehringer Ingelheim Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Boehringer Ingelheim Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-Alcoholic Steatohepatitis Biomarkers Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Non-Alcoholic Steatohepatitis Biomarkers by Company Revenue
3.2.2 Top 3 Non-Alcoholic Steatohepatitis Biomarkers Players Market Share in 2022
3.2.3 Top 6 Non-Alcoholic Steatohepatitis Biomarkers Players Market Share in 2022
3.3 Non-Alcoholic Steatohepatitis Biomarkers Market: Overall Company Footprint Analysis
3.3.1 Non-Alcoholic Steatohepatitis Biomarkers Market: Region Footprint
3.3.2 Non-Alcoholic Steatohepatitis Biomarkers Market: Company Product Type Footprint
3.3.3 Non-Alcoholic Steatohepatitis Biomarkers Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value and Market Share by Type (2018-2023)
4.2 Global Non-Alcoholic Steatohepatitis Biomarkers Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Application (2018-2023)
5.2 Global Non-Alcoholic Steatohepatitis Biomarkers Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2029)
6.2 North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2029)
6.3 North America Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country
6.3.1 North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2018-2029)
6.3.2 United States Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
6.3.3 Canada Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
6.3.4 Mexico Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2029)
7.2 Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2029)
7.3 Europe Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country
7.3.1 Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2018-2029)
7.3.2 Germany Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
7.3.3 France Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
7.3.5 Russia Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
7.3.6 Italy Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Market Size by Region
8.3.1 Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Region (2018-2029)
8.3.2 China Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
8.3.3 Japan Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
8.3.4 South Korea Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
8.3.5 India Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
8.3.7 Australia Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2029)
9.2 South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2029)
9.3 South America Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country
9.3.1 South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2018-2029)
9.3.2 Brazil Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
9.3.3 Argentina Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country
10.3.1 Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2018-2029)
10.3.2 Turkey Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
10.3.4 UAE Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Non-Alcoholic Steatohepatitis Biomarkers Market Drivers
11.2 Non-Alcoholic Steatohepatitis Biomarkers Market Restraints
11.3 Non-Alcoholic Steatohepatitis Biomarkers Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-Alcoholic Steatohepatitis Biomarkers Industry Chain
12.2 Non-Alcoholic Steatohepatitis Biomarkers Upstream Analysis
12.3 Non-Alcoholic Steatohepatitis Biomarkers Midstream Analysis
12.4 Non-Alcoholic Steatohepatitis Biomarkers Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Non-Alcoholic Steatohepatitis Biomarkers
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-Alcoholic Steatohepatitis Biomarkers by Type
1.3.1 Overview: Global Non-Alcoholic Steatohepatitis Biomarkers Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Type in 2022
1.3.3 Hepatic Fibrosis Biomarkers
1.3.4 Serum Biomarkers
1.3.5 Oxidative Stress Biomarkers
1.3.6 Apoptosis Biomarkers
1.3.7 Others
1.4 Global Non-Alcoholic Steatohepatitis Biomarkers Market by Application
1.4.1 Overview: Global Non-Alcoholic Steatohepatitis Biomarkers Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Pharmaceutical Company
1.4.4 Others
1.5 Global Non-Alcoholic Steatohepatitis Biomarkers Market Size & Forecast
1.6 Global Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast by Region
1.6.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Non-Alcoholic Steatohepatitis Biomarkers Market Size by Region, (2018-2029)
1.6.3 North America Non-Alcoholic Steatohepatitis Biomarkers Market Size and Prospect (2018-2029)
1.6.4 Europe Non-Alcoholic Steatohepatitis Biomarkers Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Market Size and Prospect (2018-2029)
1.6.6 South America Non-Alcoholic Steatohepatitis Biomarkers Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Genfit
2.1.1 Genfit Details
2.1.2 Genfit Major Business
2.1.3 Genfit Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.1.4 Genfit Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Genfit Recent Developments and Future Plans
2.2 Prometheus Laboratories
2.2.1 Prometheus Laboratories Details
2.2.2 Prometheus Laboratories Major Business
2.2.3 Prometheus Laboratories Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.2.4 Prometheus Laboratories Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Prometheus Laboratories Recent Developments and Future Plans
2.3 Siemens Medical Solutions USA
2.3.1 Siemens Medical Solutions USA Details
2.3.2 Siemens Medical Solutions USA Major Business
2.3.3 Siemens Medical Solutions USA Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.3.4 Siemens Medical Solutions USA Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Siemens Medical Solutions USA Recent Developments and Future Plans
2.4 BioPredictive
2.4.1 BioPredictive Details
2.4.2 BioPredictive Major Business
2.4.3 BioPredictive Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.4.4 BioPredictive Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BioPredictive Recent Developments and Future Plans
2.5 Quest Diagnostics
2.5.1 Quest Diagnostics Details
2.5.2 Quest Diagnostics Major Business
2.5.3 Quest Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.5.4 Quest Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Quest Diagnostics Recent Developments and Future Plans
2.6 AstraZeneca Plc.
2.6.1 AstraZeneca Plc. Details
2.6.2 AstraZeneca Plc. Major Business
2.6.3 AstraZeneca Plc. Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.6.4 AstraZeneca Plc. Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 AstraZeneca Plc. Recent Developments and Future Plans
2.7 Laboratory Corporation of America Holdings
2.7.1 Laboratory Corporation of America Holdings Details
2.7.2 Laboratory Corporation of America Holdings Major Business
2.7.3 Laboratory Corporation of America Holdings Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.7.4 Laboratory Corporation of America Holdings Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.8.4 Pfizer Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 Bristol-Myers Squibb Company
2.9.1 Bristol-Myers Squibb Company Details
2.9.2 Bristol-Myers Squibb Company Major Business
2.9.3 Bristol-Myers Squibb Company Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.9.4 Bristol-Myers Squibb Company Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
2.10 NGM Biopharmaceuticals
2.10.1 NGM Biopharmaceuticals Details
2.10.2 NGM Biopharmaceuticals Major Business
2.10.3 NGM Biopharmaceuticals Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.10.4 NGM Biopharmaceuticals Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 NGM Biopharmaceuticals Recent Developments and Future Plans
2.11 Gilead Sciences
2.11.1 Gilead Sciences Details
2.11.2 Gilead Sciences Major Business
2.11.3 Gilead Sciences Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.11.4 Gilead Sciences Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Gilead Sciences Recent Developments and Future Plans
2.12 Perspectum Diagnostics
2.12.1 Perspectum Diagnostics Details
2.12.2 Perspectum Diagnostics Major Business
2.12.3 Perspectum Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.12.4 Perspectum Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Perspectum Diagnostics Recent Developments and Future Plans
2.13 One Way Liver SL
2.13.1 One Way Liver SL Details
2.13.2 One Way Liver SL Major Business
2.13.3 One Way Liver SL Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.13.4 One Way Liver SL Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 One Way Liver SL Recent Developments and Future Plans
2.14 Enterome SA
2.14.1 Enterome SA Details
2.14.2 Enterome SA Major Business
2.14.3 Enterome SA Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.14.4 Enterome SA Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Enterome SA Recent Developments and Future Plans
2.15 Echosens SA
2.15.1 Echosens SA Details
2.15.2 Echosens SA Major Business
2.15.3 Echosens SA Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.15.4 Echosens SA Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Echosens SA Recent Developments and Future Plans
2.16 Cisbio Bioassays SAS
2.16.1 Cisbio Bioassays SAS Details
2.16.2 Cisbio Bioassays SAS Major Business
2.16.3 Cisbio Bioassays SAS Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.16.4 Cisbio Bioassays SAS Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Cisbio Bioassays SAS Recent Developments and Future Plans
2.17 Celerion Inc.
2.17.1 Celerion Inc. Details
2.17.2 Celerion Inc. Major Business
2.17.3 Celerion Inc. Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.17.4 Celerion Inc. Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Celerion Inc. Recent Developments and Future Plans
2.18 Xeptagen SpA
2.18.1 Xeptagen SpA Details
2.18.2 Xeptagen SpA Major Business
2.18.3 Xeptagen SpA Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.18.4 Xeptagen SpA Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Xeptagen SpA Recent Developments and Future Plans
2.19 Boehringer Ingelheim
2.19.1 Boehringer Ingelheim Details
2.19.2 Boehringer Ingelheim Major Business
2.19.3 Boehringer Ingelheim Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
2.19.4 Boehringer Ingelheim Non-Alcoholic Steatohepatitis Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Boehringer Ingelheim Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-Alcoholic Steatohepatitis Biomarkers Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Non-Alcoholic Steatohepatitis Biomarkers by Company Revenue
3.2.2 Top 3 Non-Alcoholic Steatohepatitis Biomarkers Players Market Share in 2022
3.2.3 Top 6 Non-Alcoholic Steatohepatitis Biomarkers Players Market Share in 2022
3.3 Non-Alcoholic Steatohepatitis Biomarkers Market: Overall Company Footprint Analysis
3.3.1 Non-Alcoholic Steatohepatitis Biomarkers Market: Region Footprint
3.3.2 Non-Alcoholic Steatohepatitis Biomarkers Market: Company Product Type Footprint
3.3.3 Non-Alcoholic Steatohepatitis Biomarkers Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value and Market Share by Type (2018-2023)
4.2 Global Non-Alcoholic Steatohepatitis Biomarkers Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Application (2018-2023)
5.2 Global Non-Alcoholic Steatohepatitis Biomarkers Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2029)
6.2 North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2029)
6.3 North America Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country
6.3.1 North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2018-2029)
6.3.2 United States Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
6.3.3 Canada Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
6.3.4 Mexico Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2029)
7.2 Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2029)
7.3 Europe Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country
7.3.1 Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2018-2029)
7.3.2 Germany Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
7.3.3 France Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
7.3.5 Russia Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
7.3.6 Italy Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Market Size by Region
8.3.1 Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Region (2018-2029)
8.3.2 China Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
8.3.3 Japan Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
8.3.4 South Korea Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
8.3.5 India Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
8.3.7 Australia Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2029)
9.2 South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2029)
9.3 South America Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country
9.3.1 South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2018-2029)
9.3.2 Brazil Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
9.3.3 Argentina Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country
10.3.1 Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2018-2029)
10.3.2 Turkey Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
10.3.4 UAE Non-Alcoholic Steatohepatitis Biomarkers Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Non-Alcoholic Steatohepatitis Biomarkers Market Drivers
11.2 Non-Alcoholic Steatohepatitis Biomarkers Market Restraints
11.3 Non-Alcoholic Steatohepatitis Biomarkers Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-Alcoholic Steatohepatitis Biomarkers Industry Chain
12.2 Non-Alcoholic Steatohepatitis Biomarkers Upstream Analysis
12.3 Non-Alcoholic Steatohepatitis Biomarkers Midstream Analysis
12.4 Non-Alcoholic Steatohepatitis Biomarkers Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Genfit Company Information, Head Office, and Major Competitors
Table 6. Genfit Major Business
Table 7. Genfit Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 8. Genfit Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Genfit Recent Developments and Future Plans
Table 10. Prometheus Laboratories Company Information, Head Office, and Major Competitors
Table 11. Prometheus Laboratories Major Business
Table 12. Prometheus Laboratories Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 13. Prometheus Laboratories Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Prometheus Laboratories Recent Developments and Future Plans
Table 15. Siemens Medical Solutions USA Company Information, Head Office, and Major Competitors
Table 16. Siemens Medical Solutions USA Major Business
Table 17. Siemens Medical Solutions USA Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 18. Siemens Medical Solutions USA Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Siemens Medical Solutions USA Recent Developments and Future Plans
Table 20. BioPredictive Company Information, Head Office, and Major Competitors
Table 21. BioPredictive Major Business
Table 22. BioPredictive Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 23. BioPredictive Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. BioPredictive Recent Developments and Future Plans
Table 25. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 26. Quest Diagnostics Major Business
Table 27. Quest Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 28. Quest Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Quest Diagnostics Recent Developments and Future Plans
Table 30. AstraZeneca Plc. Company Information, Head Office, and Major Competitors
Table 31. AstraZeneca Plc. Major Business
Table 32. AstraZeneca Plc. Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 33. AstraZeneca Plc. Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. AstraZeneca Plc. Recent Developments and Future Plans
Table 35. Laboratory Corporation of America Holdings Company Information, Head Office, and Major Competitors
Table 36. Laboratory Corporation of America Holdings Major Business
Table 37. Laboratory Corporation of America Holdings Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 38. Laboratory Corporation of America Holdings Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Laboratory Corporation of America Holdings Recent Developments and Future Plans
Table 40. Pfizer Company Information, Head Office, and Major Competitors
Table 41. Pfizer Major Business
Table 42. Pfizer Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 43. Pfizer Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Pfizer Recent Developments and Future Plans
Table 45. Bristol-Myers Squibb Company Company Information, Head Office, and Major Competitors
Table 46. Bristol-Myers Squibb Company Major Business
Table 47. Bristol-Myers Squibb Company Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 48. Bristol-Myers Squibb Company Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Bristol-Myers Squibb Company Recent Developments and Future Plans
Table 50. NGM Biopharmaceuticals Company Information, Head Office, and Major Competitors
Table 51. NGM Biopharmaceuticals Major Business
Table 52. NGM Biopharmaceuticals Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 53. NGM Biopharmaceuticals Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. NGM Biopharmaceuticals Recent Developments and Future Plans
Table 55. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 56. Gilead Sciences Major Business
Table 57. Gilead Sciences Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 58. Gilead Sciences Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Gilead Sciences Recent Developments and Future Plans
Table 60. Perspectum Diagnostics Company Information, Head Office, and Major Competitors
Table 61. Perspectum Diagnostics Major Business
Table 62. Perspectum Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 63. Perspectum Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Perspectum Diagnostics Recent Developments and Future Plans
Table 65. One Way Liver SL Company Information, Head Office, and Major Competitors
Table 66. One Way Liver SL Major Business
Table 67. One Way Liver SL Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 68. One Way Liver SL Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. One Way Liver SL Recent Developments and Future Plans
Table 70. Enterome SA Company Information, Head Office, and Major Competitors
Table 71. Enterome SA Major Business
Table 72. Enterome SA Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 73. Enterome SA Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Enterome SA Recent Developments and Future Plans
Table 75. Echosens SA Company Information, Head Office, and Major Competitors
Table 76. Echosens SA Major Business
Table 77. Echosens SA Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 78. Echosens SA Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Echosens SA Recent Developments and Future Plans
Table 80. Cisbio Bioassays SAS Company Information, Head Office, and Major Competitors
Table 81. Cisbio Bioassays SAS Major Business
Table 82. Cisbio Bioassays SAS Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 83. Cisbio Bioassays SAS Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Cisbio Bioassays SAS Recent Developments and Future Plans
Table 85. Celerion Inc. Company Information, Head Office, and Major Competitors
Table 86. Celerion Inc. Major Business
Table 87. Celerion Inc. Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 88. Celerion Inc. Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Celerion Inc. Recent Developments and Future Plans
Table 90. Xeptagen SpA Company Information, Head Office, and Major Competitors
Table 91. Xeptagen SpA Major Business
Table 92. Xeptagen SpA Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 93. Xeptagen SpA Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Xeptagen SpA Recent Developments and Future Plans
Table 95. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 96. Boehringer Ingelheim Major Business
Table 97. Boehringer Ingelheim Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 98. Boehringer Ingelheim Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Boehringer Ingelheim Recent Developments and Future Plans
Table 100. Global Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million) by Players (2018-2023)
Table 101. Global Non-Alcoholic Steatohepatitis Biomarkers Revenue Share by Players (2018-2023)
Table 102. Breakdown of Non-Alcoholic Steatohepatitis Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in Non-Alcoholic Steatohepatitis Biomarkers, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 104. Head Office of Key Non-Alcoholic Steatohepatitis Biomarkers Players
Table 105. Non-Alcoholic Steatohepatitis Biomarkers Market: Company Product Type Footprint
Table 106. Non-Alcoholic Steatohepatitis Biomarkers Market: Company Product Application Footprint
Table 107. Non-Alcoholic Steatohepatitis Biomarkers New Market Entrants and Barriers to Market Entry
Table 108. Non-Alcoholic Steatohepatitis Biomarkers Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (USD Million) by Type (2018-2023)
Table 110. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Share by Type (2018-2023)
Table 111. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Forecast by Type (2024-2029)
Table 112. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2023)
Table 113. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Forecast by Application (2024-2029)
Table 114. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2023) & (USD Million)
Table 115. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2024-2029) & (USD Million)
Table 116. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2023) & (USD Million)
Table 117. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2024-2029) & (USD Million)
Table 118. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2018-2023) & (USD Million)
Table 119. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2024-2029) & (USD Million)
Table 120. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2023) & (USD Million)
Table 123. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2024-2029) & (USD Million)
Table 124. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2023) & (USD Million)
Table 127. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2024-2029) & (USD Million)
Table 128. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2023) & (USD Million)
Table 129. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2024-2029) & (USD Million)
Table 130. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Region (2018-2023) & (USD Million)
Table 131. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Region (2024-2029) & (USD Million)
Table 132. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2023) & (USD Million)
Table 133. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2024-2029) & (USD Million)
Table 134. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2023) & (USD Million)
Table 135. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2024-2029) & (USD Million)
Table 136. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2018-2023) & (USD Million)
Table 137. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2023) & (USD Million)
Table 139. Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2024-2029) & (USD Million)
Table 140. Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2023) & (USD Million)
Table 141. Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2024-2029) & (USD Million)
Table 142. Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2018-2023) & (USD Million)
Table 143. Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2024-2029) & (USD Million)
Table 144. Non-Alcoholic Steatohepatitis Biomarkers Raw Material
Table 145. Key Suppliers of Non-Alcoholic Steatohepatitis Biomarkers Raw Materials
Table 1. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Genfit Company Information, Head Office, and Major Competitors
Table 6. Genfit Major Business
Table 7. Genfit Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 8. Genfit Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Genfit Recent Developments and Future Plans
Table 10. Prometheus Laboratories Company Information, Head Office, and Major Competitors
Table 11. Prometheus Laboratories Major Business
Table 12. Prometheus Laboratories Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 13. Prometheus Laboratories Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Prometheus Laboratories Recent Developments and Future Plans
Table 15. Siemens Medical Solutions USA Company Information, Head Office, and Major Competitors
Table 16. Siemens Medical Solutions USA Major Business
Table 17. Siemens Medical Solutions USA Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 18. Siemens Medical Solutions USA Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Siemens Medical Solutions USA Recent Developments and Future Plans
Table 20. BioPredictive Company Information, Head Office, and Major Competitors
Table 21. BioPredictive Major Business
Table 22. BioPredictive Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 23. BioPredictive Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. BioPredictive Recent Developments and Future Plans
Table 25. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 26. Quest Diagnostics Major Business
Table 27. Quest Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 28. Quest Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Quest Diagnostics Recent Developments and Future Plans
Table 30. AstraZeneca Plc. Company Information, Head Office, and Major Competitors
Table 31. AstraZeneca Plc. Major Business
Table 32. AstraZeneca Plc. Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 33. AstraZeneca Plc. Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. AstraZeneca Plc. Recent Developments and Future Plans
Table 35. Laboratory Corporation of America Holdings Company Information, Head Office, and Major Competitors
Table 36. Laboratory Corporation of America Holdings Major Business
Table 37. Laboratory Corporation of America Holdings Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 38. Laboratory Corporation of America Holdings Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Laboratory Corporation of America Holdings Recent Developments and Future Plans
Table 40. Pfizer Company Information, Head Office, and Major Competitors
Table 41. Pfizer Major Business
Table 42. Pfizer Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 43. Pfizer Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Pfizer Recent Developments and Future Plans
Table 45. Bristol-Myers Squibb Company Company Information, Head Office, and Major Competitors
Table 46. Bristol-Myers Squibb Company Major Business
Table 47. Bristol-Myers Squibb Company Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 48. Bristol-Myers Squibb Company Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Bristol-Myers Squibb Company Recent Developments and Future Plans
Table 50. NGM Biopharmaceuticals Company Information, Head Office, and Major Competitors
Table 51. NGM Biopharmaceuticals Major Business
Table 52. NGM Biopharmaceuticals Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 53. NGM Biopharmaceuticals Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. NGM Biopharmaceuticals Recent Developments and Future Plans
Table 55. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 56. Gilead Sciences Major Business
Table 57. Gilead Sciences Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 58. Gilead Sciences Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Gilead Sciences Recent Developments and Future Plans
Table 60. Perspectum Diagnostics Company Information, Head Office, and Major Competitors
Table 61. Perspectum Diagnostics Major Business
Table 62. Perspectum Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 63. Perspectum Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Perspectum Diagnostics Recent Developments and Future Plans
Table 65. One Way Liver SL Company Information, Head Office, and Major Competitors
Table 66. One Way Liver SL Major Business
Table 67. One Way Liver SL Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 68. One Way Liver SL Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. One Way Liver SL Recent Developments and Future Plans
Table 70. Enterome SA Company Information, Head Office, and Major Competitors
Table 71. Enterome SA Major Business
Table 72. Enterome SA Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 73. Enterome SA Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Enterome SA Recent Developments and Future Plans
Table 75. Echosens SA Company Information, Head Office, and Major Competitors
Table 76. Echosens SA Major Business
Table 77. Echosens SA Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 78. Echosens SA Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Echosens SA Recent Developments and Future Plans
Table 80. Cisbio Bioassays SAS Company Information, Head Office, and Major Competitors
Table 81. Cisbio Bioassays SAS Major Business
Table 82. Cisbio Bioassays SAS Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 83. Cisbio Bioassays SAS Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Cisbio Bioassays SAS Recent Developments and Future Plans
Table 85. Celerion Inc. Company Information, Head Office, and Major Competitors
Table 86. Celerion Inc. Major Business
Table 87. Celerion Inc. Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 88. Celerion Inc. Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Celerion Inc. Recent Developments and Future Plans
Table 90. Xeptagen SpA Company Information, Head Office, and Major Competitors
Table 91. Xeptagen SpA Major Business
Table 92. Xeptagen SpA Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 93. Xeptagen SpA Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Xeptagen SpA Recent Developments and Future Plans
Table 95. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 96. Boehringer Ingelheim Major Business
Table 97. Boehringer Ingelheim Non-Alcoholic Steatohepatitis Biomarkers Product and Solutions
Table 98. Boehringer Ingelheim Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Boehringer Ingelheim Recent Developments and Future Plans
Table 100. Global Non-Alcoholic Steatohepatitis Biomarkers Revenue (USD Million) by Players (2018-2023)
Table 101. Global Non-Alcoholic Steatohepatitis Biomarkers Revenue Share by Players (2018-2023)
Table 102. Breakdown of Non-Alcoholic Steatohepatitis Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in Non-Alcoholic Steatohepatitis Biomarkers, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 104. Head Office of Key Non-Alcoholic Steatohepatitis Biomarkers Players
Table 105. Non-Alcoholic Steatohepatitis Biomarkers Market: Company Product Type Footprint
Table 106. Non-Alcoholic Steatohepatitis Biomarkers Market: Company Product Application Footprint
Table 107. Non-Alcoholic Steatohepatitis Biomarkers New Market Entrants and Barriers to Market Entry
Table 108. Non-Alcoholic Steatohepatitis Biomarkers Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (USD Million) by Type (2018-2023)
Table 110. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Share by Type (2018-2023)
Table 111. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Forecast by Type (2024-2029)
Table 112. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2023)
Table 113. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Forecast by Application (2024-2029)
Table 114. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2023) & (USD Million)
Table 115. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2024-2029) & (USD Million)
Table 116. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2023) & (USD Million)
Table 117. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2024-2029) & (USD Million)
Table 118. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2018-2023) & (USD Million)
Table 119. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2024-2029) & (USD Million)
Table 120. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2023) & (USD Million)
Table 123. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2024-2029) & (USD Million)
Table 124. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2023) & (USD Million)
Table 127. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2024-2029) & (USD Million)
Table 128. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2023) & (USD Million)
Table 129. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2024-2029) & (USD Million)
Table 130. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Region (2018-2023) & (USD Million)
Table 131. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Region (2024-2029) & (USD Million)
Table 132. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2023) & (USD Million)
Table 133. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2024-2029) & (USD Million)
Table 134. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2023) & (USD Million)
Table 135. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2024-2029) & (USD Million)
Table 136. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2018-2023) & (USD Million)
Table 137. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2018-2023) & (USD Million)
Table 139. Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type (2024-2029) & (USD Million)
Table 140. Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2018-2023) & (USD Million)
Table 141. Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Application (2024-2029) & (USD Million)
Table 142. Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2018-2023) & (USD Million)
Table 143. Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Country (2024-2029) & (USD Million)
Table 144. Non-Alcoholic Steatohepatitis Biomarkers Raw Material
Table 145. Key Suppliers of Non-Alcoholic Steatohepatitis Biomarkers Raw Materials
LIST OF FIGURES
Figure 1. Non-Alcoholic Steatohepatitis Biomarkers Picture
Figure 2. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Type in 2022
Figure 4. Hepatic Fibrosis Biomarkers
Figure 5. Serum Biomarkers
Figure 6. Oxidative Stress Biomarkers
Figure 7. Apoptosis Biomarkers
Figure 8. Others
Figure 9. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Application in 2022
Figure 11. Hospital Picture
Figure 12. Pharmaceutical Company Picture
Figure 13. Others Picture
Figure 14. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Region in 2022
Figure 19. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Non-Alcoholic Steatohepatitis Biomarkers Revenue Share by Players in 2022
Figure 25. Non-Alcoholic Steatohepatitis Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Non-Alcoholic Steatohepatitis Biomarkers Market Share in 2022
Figure 27. Global Top 6 Players Non-Alcoholic Steatohepatitis Biomarkers Market Share in 2022
Figure 28. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Share by Type (2018-2023)
Figure 29. Global Non-Alcoholic Steatohepatitis Biomarkers Market Share Forecast by Type (2024-2029)
Figure 30. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Share by Application (2018-2023)
Figure 31. Global Non-Alcoholic Steatohepatitis Biomarkers Market Share Forecast by Application (2024-2029)
Figure 32. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 42. France Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Region (2018-2029)
Figure 49. China Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 52. India Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 66. Non-Alcoholic Steatohepatitis Biomarkers Market Drivers
Figure 67. Non-Alcoholic Steatohepatitis Biomarkers Market Restraints
Figure 68. Non-Alcoholic Steatohepatitis Biomarkers Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Non-Alcoholic Steatohepatitis Biomarkers in 2022
Figure 71. Manufacturing Process Analysis of Non-Alcoholic Steatohepatitis Biomarkers
Figure 72. Non-Alcoholic Steatohepatitis Biomarkers Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Non-Alcoholic Steatohepatitis Biomarkers Picture
Figure 2. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Type in 2022
Figure 4. Hepatic Fibrosis Biomarkers
Figure 5. Serum Biomarkers
Figure 6. Oxidative Stress Biomarkers
Figure 7. Apoptosis Biomarkers
Figure 8. Others
Figure 9. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Application in 2022
Figure 11. Hospital Picture
Figure 12. Pharmaceutical Company Picture
Figure 13. Others Picture
Figure 14. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Region in 2022
Figure 19. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Non-Alcoholic Steatohepatitis Biomarkers Revenue Share by Players in 2022
Figure 25. Non-Alcoholic Steatohepatitis Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Non-Alcoholic Steatohepatitis Biomarkers Market Share in 2022
Figure 27. Global Top 6 Players Non-Alcoholic Steatohepatitis Biomarkers Market Share in 2022
Figure 28. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Share by Type (2018-2023)
Figure 29. Global Non-Alcoholic Steatohepatitis Biomarkers Market Share Forecast by Type (2024-2029)
Figure 30. Global Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Share by Application (2018-2023)
Figure 31. Global Non-Alcoholic Steatohepatitis Biomarkers Market Share Forecast by Application (2024-2029)
Figure 32. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 42. France Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Region (2018-2029)
Figure 49. China Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 52. India Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Non-Alcoholic Steatohepatitis Biomarkers Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Non-Alcoholic Steatohepatitis Biomarkers Consumption Value (2018-2029) & (USD Million)
Figure 66. Non-Alcoholic Steatohepatitis Biomarkers Market Drivers
Figure 67. Non-Alcoholic Steatohepatitis Biomarkers Market Restraints
Figure 68. Non-Alcoholic Steatohepatitis Biomarkers Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Non-Alcoholic Steatohepatitis Biomarkers in 2022
Figure 71. Manufacturing Process Analysis of Non-Alcoholic Steatohepatitis Biomarkers
Figure 72. Non-Alcoholic Steatohepatitis Biomarkers Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
